Nexgel (NXGL) EBITDA (2018 - 2025)
Nexgel (NXGL) reported EBITDA of $1.5 million for Q4 2025, up 281.93% on a YoY basis from $400600.9 in Q4 2024, and up 311.03% quarter-over-quarter from -$725000.0 in Q3 2025.
Nexgel (NXGL) EBITDA (2018 - 2025) Analysis & Trends
Nexgel has reported EBITDA for 8 years, with the latest figure at $1.5 million in Q4 2025.
- For the quarter ending Q4 2025, EBITDA rose 281.93% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at -$608000.0 (up 82.89% YoY), and the FY2025 full-year result was -$608000.0, up 82.89% from the prior year.
- EBITDA for Q4 2025 stood at $1.5 million, up from -$725000.0 in the prior quarter.
- The five-year high for EBITDA was $1.5 million in Q4 2025, with the low at -$1.2 million in Q4 2023.
- Historically, EBITDA has averaged -$677800.0 across 5 years, with a median of -$779000.0 in 2022.
- Annual changes were most pronounced in 2022 — EBITDA sank 70.0% — and 2025, when it jumped 281.93%.
- Nexgel's EBITDA stood at -$887000.0 in 2021, then advanced by 11.95% to -$781000.0 in 2022, then slumped by 56.08% to -$1.2 million in 2023, then surged by 31.01% to -$841000.0 in 2024, then jumped by 281.93% to $1.5 million in 2025.
- The last three EBITDA figures came in at $1.5 million (Q4 2025), -$725000.0 (Q3 2025), and -$636000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 799.70 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 93.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 120.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 499.81 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 177.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 81.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -107.10 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 141.96 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 66.00 Mn |
| 10 | Nexgel | 4.18 Mn | 2.81 Mn | 819,000.00 | 1.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | -725,000.00 |
| Jun 30, 2025 | -636,000.00 |
| Mar 31, 2025 | -777,000.00 |
| Dec 31, 2024 | -841,000.00 |
| Sep 30, 2024 | -788,000.00 |
| Jun 30, 2024 | -1.05 Mn |
| Mar 31, 2024 | -871,000.00 |
| Dec 31, 2023 | -1.22 Mn |
| Sep 30, 2023 | -612,000.00 |
| Jun 30, 2023 | -762,000.00 |
| Mar 31, 2023 | -883,000.00 |
| Dec 31, 2022 | -781,000.00 |
| Sep 30, 2022 | -1.04 Mn |
| Jun 30, 2022 | -718,000.00 |
| Mar 31, 2022 | -812,000.00 |
| Dec 31, 2021 | -887,000.00 |
| Sep 30, 2021 | -610,000.00 |
| Jun 30, 2021 | -553,000.00 |
| Mar 31, 2021 | -520,000.00 |